Ajax-Loading

Sumitomo Dainippon Pharma Co Ltd - Enterprise Value To Sales Ratio

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March.

The item "Enterprise-Value-To-Sales-Ratio" stands at 1.39 as of 09/30/2025.

As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Enterprise Value To Sales Ratio" stands at 1.39. This represents an increase of 37.69 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -7.56 percent compared to the value the year prior.
The 1 year change in percent is -7.56.
The 3 year change in percent is 114.83.

The Serie's long term average value is 1.14. It's latest available value, on 09/30/2025, is 21.84 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is +130.43%.
The Serie's change in percent from it's maximum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is -20.73%.

Enterprise Value To Sales Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Enterprise Value To Sales Ratio905,699,262,464.00
LogoJohnson & Johnson - Enterprise Value To Sales Ratio486,508,953,600.00
LogoAbbVie Inc - Enterprise Value To Sales Ratio399,570,305,024.00
LogoRoche Holding AG - Enterprise Value To Sales Ratio317,433,206,677.55
LogoAstraZeneca PLC - Enterprise Value To Sales Ratio280,205,508,085.11